These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
495 related items for PubMed ID: 15673582
21. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD. Flapper BC, Schoemaker MM. Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997 [Abstract] [Full Text] [Related]
22. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. Spencer TJ, Abikoff HB, Connor DF, Biederman J, Pliszka SR, Boellner S, Read SC, Pratt R. Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455 [Abstract] [Full Text] [Related]
24. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L, Adult ADHD Research Group. Biol Psychiatry; 2007 Jun 15; 61(12):1380-7. PubMed ID: 17137560 [Abstract] [Full Text] [Related]
25. Determinants of quality of life in children with Gilles de la Tourette syndrome. Bernard BA, Stebbins GT, Siegel S, Schultz TM, Hays C, Morrissey MJ, Leurgans S, Goetz CG. Mov Disord; 2009 May 15; 24(7):1070-3. PubMed ID: 19306279 [Abstract] [Full Text] [Related]
26. Interpreting parental proxy reports of (health-related) quality of life for children with unilateral cochlear implants. Sach TH, Barton GR. Int J Pediatr Otorhinolaryngol; 2007 Mar 15; 71(3):435-45. PubMed ID: 17161471 [Abstract] [Full Text] [Related]
27. Children's and parents' perspectives on open-label use of placebos in the treatment of ADHD. Sandler A, Glesne C, Geller G. Child Care Health Dev; 2008 Jan 15; 34(1):111-20. PubMed ID: 18171452 [Abstract] [Full Text] [Related]
28. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, Rohde LA. Arch Gen Psychiatry; 2007 Feb 15; 64(2):218-24. PubMed ID: 17283289 [Abstract] [Full Text] [Related]
29. Symptoms of inattention and hyperactivity in children with habitual snoring: evidence from a community-based study in Istanbul. Arman AR, Ersu R, Save D, Karadag B, Karaman G, Karabekiroglu K, Karakoc F, Dagli E, Berkem M. Child Care Health Dev; 2005 Nov 15; 31(6):707-17. PubMed ID: 16207229 [Abstract] [Full Text] [Related]
31. Health-related quality of life (HRQL) scores reported from parents and their children with chronic illness differed depending on utility elicitation method. Sung L, Young NL, Greenberg ML, McLimont M, Samanta T, Wong J, Rubenstein J, Ingber S, Doyle JJ, Feldman BM. J Clin Epidemiol; 2004 Nov 27; 57(11):1161-6. PubMed ID: 15567632 [Abstract] [Full Text] [Related]
32. Adaptive changes related to medication treatment of ADHD: listening to parents of children in clinical trials of a novel nonstimulant medication. Saylor KE, Buermeyer CM, Spencer TJ, Barkley RA. J Clin Psychiatry; 2002 Nov 27; 63 Suppl 12():23-8. PubMed ID: 12562058 [Abstract] [Full Text] [Related]
33. Treatment of ADHD with amphetamine: short-term effects on family interaction. Gustafsson P, Hansson K, Eidevall L, Thernlund G, Svedin CG. J Atten Disord; 2008 Jul 27; 12(1):83-91. PubMed ID: 17968029 [Abstract] [Full Text] [Related]
34. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P. Child Care Health Dev; 2006 Sep 27; 32(5):575-83. PubMed ID: 16919137 [Abstract] [Full Text] [Related]
35. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine. Adler LA, Sutton VK, Moore RJ, Dietrich AP, Reimherr FW, Sangal RB, Saylor KE, Secnik K, Kelsey DK, Allen AJ. J Clin Psychopharmacol; 2006 Dec 27; 26(6):648-52. PubMed ID: 17110824 [Abstract] [Full Text] [Related]
36. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder. Brinkman WB, Sherman SN, Zmitrovich AR, Visscher MO, Crosby LE, Phelan KJ, Donovan EF. Pediatrics; 2009 Aug 27; 124(2):580-9. PubMed ID: 19651580 [Abstract] [Full Text] [Related]
37. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Findling RL. Clin Ther; 2008 May 27; 30(5):942-57. PubMed ID: 18555941 [Abstract] [Full Text] [Related]
38. New options in the pharmacological management of attention-deficit/hyperactivity disorder. Olfson M. Am J Manag Care; 2004 Jul 27; 10(4 Suppl):S117-24. PubMed ID: 15352538 [Abstract] [Full Text] [Related]
39. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2010 Nov 12; 59(44):1439-43. PubMed ID: 21063274 [Abstract] [Full Text] [Related]
40. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML, American Academy of Pediatrics Committee on Quality Improvement, American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder. Pediatrics; 2005 Jun 12; 115(6):e749-57. PubMed ID: 15930203 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]